Evidence map›Paper›PMID 28611295›Full record

ArticleOncotarget2017

Assessment of concordance between fresh-frozen and formalin-fixed paraffin embedded tumor DNA methylation using a targeted sequencing approach.

Bruce Moran, Sudipto Das, Dominiek Smeets, Gillian Peutman, Rut Klinger, Bozena Fender, Kate Connor, Matthias Ebert, Timo Gaiser, Jochen Hm Prehn and 9 more

Abstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Epigenetic differences in the tumor suppressor genesInnovative surgical sciences · 2024
    Article
  6. Article
  7. The Role of theBiomedicines · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Bruce MoranDepartment of Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.
Sudipto DasDepartment of Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.
Dominiek SmeetsDepartment of Oncology, Laboratory of Translational Genetics, VIB Center for Cancer Biology, Leuven, Belgium.
Gillian PeutmanDepartment of Oncology, Laboratory of Translational Genetics, VIB Center for Cancer Biology, Leuven, Belgium.
Rut KlingerDepartment of Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.
Bozena FenderOncoMark Ltd., NovaUCD, Belfield Innovation Park, Dublin, Ireland.
Kate ConnorDepartment of Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.
Matthias EbertDepartment of Internal Medicine, University of Heidelberg, Mannheim, Germany.
Timo GaiserDepartment of Internal Medicine, University of Heidelberg, Mannheim, Germany.
Jochen Hm PrehnDepartment of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland.
Orna BaconDepartment of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland.
Elaine KayDepartment of Pathology, Beaumont Hospital, Dublin, Ireland.
Bryan HennessyDepartment of Pathology, Beaumont Hospital, Dublin, Ireland.
Verena MurphyCancer Trials Ireland, Dublin, Ireland.
Bauke YlstraDepartment of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
Diether LambrechtsDepartment of Oncology, Laboratory of Translational Genetics, VIB Center for Cancer Biology, Leuven, Belgium.
Annette T ByrneDepartment of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland.
William M GallagherOncoMark Ltd., NovaUCD, Belfield Innovation Park, Dublin, Ireland.
Darran P O'ConnorDepartment of Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.

Funding

European Research Council 617595
6 · The paper itself

Abstract

DNA methylation is altered in many types of disease, including metastatic colorectal cancer. However, the methylome has not yet been fully described in archival formalin-fixed paraffin embedded (FFPE) samples in the context of matched fresh-frozen (FF) tumor material at base-pair resolution using a targeted approach. Using next-generation sequencing, we investigated three pairs of matched FFPE and FF samples to determine the extent of their similarity. We identified a 'bowing' pattern specific to FFPE samples categorized by a lower CG proportion at the start of sequence reads. We have found no evidence that this affected methylation calling, nor concordance of results. We also found no significant increase in deamination, measured by C>T transitions, previously considered a result of crosslinking DNA by formalin fixation and a barrier to the use of FFPE in methylation studies. The methods used in this study have shown sensitivity of between 60-70% based on positions also methylated in colorectal cancer cell lines. We demonstrate that FFPE material is a useful source of tumor material for methylation studies using targeted sequencing.

Indexed as

DNA MethylationDNA, NeoplasmEpigenesis, GeneticBiopsyCell Line, TumorEpigenomicsGene Expression ProfilingHigh-Throughput Nucleotide SequencingHumansMutationNeoplasmsReproducibility of ResultsSensitivity and SpecificityDNA, NeoplasmepigeneticsFFPEmethylationtargeted bisulfite sequencingtumor preservation

Identifiers

PMID28611295
PMCPMC5564631

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.